didodecyldimethylammonium has been researched along with Colonic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fathi, M; Nedaei, K; Ramazani, A; Rostamizadeh, K; Shahidi, S | 1 |
1 other study(ies) available for didodecyldimethylammonium and Colonic Neoplasms
| Article | Year |
|---|---|
Combination of Quercetin or/and siRNA-loaded DDAB-mPEG-PCL hybrid nanoparticles reverse resistance to Regorafenib in colon cancer cells.
Topics: Colonic Neoplasms; Humans; Nanoparticles; Quercetin; RNA, Small Interfering | 2022 |